Company / PP&E per Share
NewAmsterdam Pharma Co N.V. PP&E per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2025
5-year range
$0.00 / $0.00
FY2022-FY2025
Trend
+26.1%
vs FY2024
Sector context
#178 of 194
Health Care
What the data says
Among 194 Health Care companies, NewAmsterdam Pharma Co N.V. is in the bottom 8% for pp&e per share. Improved from $0.00 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025 with a 3-year CAGR of +21.7%.
Improved from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +21.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 194This company $0.00 Sector average $23.91
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share increased 26.1% year-over-year.
- Ranks #178 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +26.1% |
| FY2024 | $0.00 | +358.1% |
| FY2023 | $0.00 | -68.8% |
| FY2022 | $0.00 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026